AB-DR7
|
|
|---|---|
| CEPA | Lactobacillus plantarum DR7 |
| DOSIS | 1B UFC/día |
| NIVEL DE RECOMENDACIÓN |
II (Chong et al. 2019) |
Neuraxbiotic Zen
|
|
|---|---|
| CEPA | Lactobacillus plantarum DR7 |
| DOSIS | 1B UFC/día |
| NIVEL DE RECOMENDACIÓN |
II (Chong et al. 2019) |
Neuraxbiotic Zen
|
|
|---|---|
| CEPA | L. plantarum PS128 |
| DOSIS | 30B UFC/día |
| NIVEL DE RECOMENDACIÓN |
II(H. M. Chen et al. 2021) |
Stress Repair
|
|
|---|---|
| CEPA | Lactobacillus casei W56 Lactobacillus acidophilus W22 Lactobacillus paracasei W20 Bifidobacterium lactis W51 Lactobacillus salivarius W24 Lactococcus lactis W19 Bifidobacterium lactis W52 Lactobacillus plantarum W62 Bifidobacterium bifidum W23 |
| DOSIS | 7,5B o 15B UFC/día |
| NIVEL DE RECOMENDACIÓN |
II(Cheng et al. 2019; Picó-Monllor et al. 2023) |
Probinerv
|
|
|---|---|
| CEPA | Lactobacillus helveticus Rosell-52 (90%) Bifidobacterium longum Rosell-175 (10%) |
| DOSIS | 3B UFC/día |
| NIVEL DE RECOMENDACIÓN |
II (Gawlik-Kotelnicka et al. 2021; Skowrońska et al. 2023; Ullah et al. 2022) |
Zenflore
|
|
|---|---|
| CEPA | Bifidobacterium longum 1714 |
| DOSIS | 1B UFC/día |
| NIVEL DE RECOMENDACIÓN |
II (A.P. et al. 2016; H. Wang et al. 2019; H. et al. 2018; Allen et al. 2016; Patterson et al. 2024; Moloney et al. 2021) |